- call +1-201-465-4211
- email sales@mrinsights.biz
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
Scope of the Report:
This report focuses on the HPV Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners. They can be spread by vaginal, anal, and oral sex (1). Other HPV types are responsible for non-genital warts, which are not sexually transmitted. The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. North America and Europe accounts for the maximum market share of the global HPV vaccines market and is expected to grow at highest CAGR during the forecast period.
The worldwide market for HPV Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Adolescents
Adults
Market Segment by Applications, can be divided into
Male
Female
There are 15 Chapters to deeply display the global HPV Vaccines market.
Chapter 1, to describe HPV Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of HPV Vaccines, with sales, revenue, and price of HPV Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of HPV Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, HPV Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe HPV Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 HPV Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Adolescents
1.2.2 Adults
1.3 Market Analysis by Applications
1.3.1 Male
1.3.2 Female
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Business Overview
2.1.2 HPV Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Pharma HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 CSL
2.2.1 Business Overview
2.2.2 HPV Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CSL HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Emergent BioSolutions
2.3.1 Business Overview
2.3.2 HPV Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Emergent BioSolutions HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 HPV Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 HPV Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 MedImmune
2.6.1 Business Overview
2.6.2 HPV Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MedImmune HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 HPV Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 HPV Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi Pasteur
2.9.1 Business Overview
2.9.2 HPV Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Pasteur HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Serum Institute
2.10.1 Business Overview
2.10.2 HPV Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Serum Institute HPV Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global HPV Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global HPV Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global HPV Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 HPV Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 HPV Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global HPV Vaccines Market Analysis by Regions
4.1 Global HPV Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global HPV Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global HPV Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America HPV Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe HPV Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific HPV Vaccines Sales and Growth Rate (2013-2018)
4.5 South America HPV Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa HPV Vaccines Sales and Growth Rate (2013-2018)
5 North America HPV Vaccines by Countries
5.1 North America HPV Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America HPV Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America HPV Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States HPV Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada HPV Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico HPV Vaccines Sales and Growth Rate (2013-2018)
6 Europe HPV Vaccines by Countries
6.1 Europe HPV Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe HPV Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe HPV Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany HPV Vaccines Sales and Growth Rate (2013-2018)
6.3 UK HPV Vaccines Sales and Growth Rate (2013-2018)
6.4 France HPV Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia HPV Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy HPV Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific HPV Vaccines by Countries
7.1 Asia-Pacific HPV Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific HPV Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific HPV Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China HPV Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan HPV Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea HPV Vaccines Sales and Growth Rate (2013-2018)
7.5 India HPV Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia HPV Vaccines Sales and Growth Rate (2013-2018)
8 South America HPV Vaccines by Countries
8.1 South America HPV Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America HPV Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America HPV Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil HPV Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina HPV Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia HPV Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa HPV Vaccines by Countries
9.1 Middle East and Africa HPV Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa HPV Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa HPV Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia HPV Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE HPV Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt HPV Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria HPV Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa HPV Vaccines Sales and Growth Rate (2013-2018)
10 Global HPV Vaccines Market Segment by Type
10.1 Global HPV Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global HPV Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global HPV Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Adolescents Sales Growth and Price
10.2.1 Global Adolescents Sales Growth (2013-2018)
10.2.2 Global Adolescents Price (2013-2018)
10.3 Adults Sales Growth and Price
10.3.1 Global Adults Sales Growth (2013-2018)
10.3.2 Global Adults Price (2013-2018)
11 Global HPV Vaccines Market Segment by Application
11.1 Global HPV Vaccines Sales Market Share by Application (2013-2018)
11.2 Male Sales Growth (2013-2018)
11.3 Female Sales Growth (2013-2018)
12 HPV Vaccines Market Forecast (2018-2023)
12.1 Global HPV Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 HPV Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America HPV Vaccines Market Forecast (2018-2023)
12.2.2 Europe HPV Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific HPV Vaccines Market Forecast (2018-2023)
12.2.4 South America HPV Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa HPV Vaccines Market Forecast (2018-2023)
12.3 HPV Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global HPV Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global HPV Vaccines Market Share Forecast by Type (2018-2023)
12.4 HPV Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global HPV Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global HPV Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure HPV Vaccines Picture
Table Product Specifications of HPV Vaccines
Figure Global Sales Market Share of HPV Vaccines by Types in 2017
Table HPV Vaccines T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
